Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Cyclin-dependent kinase 1 (CDK1) |
Target Info
|
Inhibitor |
[2] |
| Extracellular signal-regulated kinase 2 (ERK2) |
Target Info
|
Inhibitor |
[2] |
| Glycogen synthase kinase-3 alpha (GSK-3A) |
Target Info
|
Inhibitor |
[1] |
| Glycogen synthase kinase-3 beta (GSK-3B) |
Target Info
|
Inhibitor |
[2] |
| References |
Top |
| REF 1 |
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015).Expert Opin Ther Pat. 2017 Jun;27(6):657-666.
|
| REF 2 |
Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes. 2003 Mar;52(3):588-95.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
